BHVN — Biohaven Cashflow Statement
0.000.00%
Last trade - 00:00- $1.44bn
- $1.12bn
Annual cashflow statement for Biohaven, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -119 | -214 | -570 | -408 | -846 |
| Depreciation | |||||
| Non-Cash Items | 33.7 | 64.9 | 300 | 44.9 | 239 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 8.98 | 1.66 | -28.6 | 24.6 | 16.8 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -76 | -146 | -298 | -332 | -582 |
| Capital Expenditures | -2.7 | -0.938 | -6.07 | -3.05 | -4.05 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 1.88 | -299 | 133 | -241 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.7 | 0.944 | -305 | 130 | -245 |
| Financing Cash Flow Items | 152 | 138 | 484 | -31.3 | 11.6 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 152 | 138 | 768 | 212 | 678 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 73.6 | -6.45 | 166 | 9.52 | -150 |